PAYOFF LETTERPurchase Agreement • January 14th, 2008 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations
Reference is made to (i) that certain Note Purchase Agreement (the “Note Agreement”) dated as of February 2006 by and among Convivia, Inc., a Delaware corporation (“Obligor”) and Harold Snyder (“Obligee”), (ii) that certain Secured Promissory Note (the “Note”) dated as of February 16, 2006 of Obligor in favor of Obligee in the principal amount of One Hundred Sixteen Thousand One Hundred Dollars ($116,100), bearing an interest rate of five percent (5.0%) per annum, (iii) that certain Security Agreement (the “Security Agreement”) dated as of February 2006 by and among Obligor and Obligee, and (iv) that certain Intellectual Property Security Agreement (the “IP Security Agreement”) dated as of February 2006 by and among Obligor and Obligee, and the various financing agreements related thereto (collectively, each as amended from time to time, the “Financing Documents”). Obligee understands that, on the Payoff Date (as hereinafter defined), Obligor expects to repay in full all of the obligat
EMPLOYMENT AGREEMENTEmployment Agreement • January 14th, 2008 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into as of September 7, 2007 (the “Effective Date”) between Bennu Pharmaceuticals Inc., a Delaware corporation with its principal offices located at 9 Commercial Blvd., Suite 200, Novato, CA 94949 (the “Company”), and Thomas E. Daley, a resident of San Mateo, California (the “Employee”).
LOAN AGREEMENT betweenLoan Agreement • January 14th, 2008 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 14th, 2008 • Raptor Pharmaceuticals Corp. • Pharmaceutical preparations • California
This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of October 17, 2007 (the “Effective Date”), by and between Bennu Pharmaceuticals Inc., a Delaware corporation (“Buyer”), Raptor Pharmaceuticals Corp., a Delaware corporation (“Parent”) (for the limited purpose of the obligations set forth in Section 6.4), Thomas E. Daley (“Daley”) and Convivia, Inc., a Delaware corporation (“Seller”, and collectively with Daley, the “Convivia Parties”). Buyer, Parent and the Convivia Parties are each referred to herein individually as a “Party” and collectively as the “Parties.”
